EURESIS PARTNERS

What EURESIS PARTNERS does

Euresis Partners is a Paris-based healthcare strategic consulting firm founded in January 2021 by five partners with senior-level operating experience at major pharmaceutical companies (AstraZeneca, Sanofi, Novartis, Bristol-Myers-Squibb, Rhône-Poulenc Rorer) and leading consulting firms. The firm provides advisory services across the full healthcare product lifecycle, organized into twelve expertise modules: clinical development, regulatory affairs (Europe), market access, medical affairs, real-world evidence, public affairs, product lifecycle management, operational excellence, valuation of opportunities, organisational optimisation, Europe implementation, and marketing/promotion strategy. Its proprietary "Evidence Generation Methodology" underpins engagements targeting pharmaceutical companies, biotechnology firms, medical device companies, e-health companies, medically positioned dietary supplements, and public/private healthcare partnerships primarily in France and Europe.

The business operates as an independent consulting partnership owned and operated by its five founding partners — Philippe Géhin (health economics, market access), Robert Dahan (clinical methodology, regulatory), Edgard Bertrand (commercial excellence, European scale-up), Véronique Ameye (public affairs, institutional relations), and Bernard Hamelin (clinical development, real-world evidence). Revenue is generated through professional services engagements delivered directly by senior partners, with consulting fees negotiated on a per-engagement basis. The firm has no proprietary technology platform, no APIs, and no app offerings; its core technology is partner expertise and a codified methodology for evidence generation across the drug lifecycle.

Go-to-market is sales-led and relationship-driven, leveraging partners' inherited networks from prior executive roles at major pharmaceutical companies. The firm markets primarily through its website blog (thought leadership articles on drug evaluation, market access, clinical development, and healthcare policy) and organic social media presence on LinkedIn and Facebook. No external funding rounds, parent company, subsidiaries, or public-private ownership structures have been disclosed.

Name

EURESIS PARTNERS

Legal name

Euresis Partners

Website

https://euresispartners.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Euresis Partners is a Paris-based healthcare strategic consulting firm founded in 2021 by five partners with senior pharmaceutical industry experience, advising pharma, biotech, medical device, and e-health companies on clinical development, regulatory, market access, and lifecycle strategy across France and Europe.

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Strategic Healthcare Consulting: Professional consulting services for healthcare sector including strategic advisory, market access strategy, clinical development consulting, regulatory affairs, and organizational transformation. Revenue is generated through client engagements and consulting mandates with pharmaceutical, biotech, medical device companies, and healthcare organizations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Euresis Partners is a healthcare strategic consulting group offering partner-led advisory and operational support across the pharmaceutical, biotechnology, medical device, e-health, and dietary supplement sectors. Its service portfolio covers clinical development, European regulatory affairs, market access, medical affairs, real-world evidence, public affairs, product life cycle management, operational excellence, organisations optimisation, valuation of opportunities, and Europe implementation. Engagements are delivered directly by five founding partners with senior operating experience in major pharmaceutical groups.

Product overview

EURESIS PARTNERS is a healthcare strategic consulting group comprising five partners with international experience in pharmaceutical groups and consulting firms. The company offers a unified consulting service portfolio organized around 12 core expertise areas spanning the entire healthcare product lifecycle: clinical development, regulatory affairs, market access, medical affairs, real-world evidence, public affairs, marketing/promotion, product lifecycle management, operational excellence, valuation of opportunities, organizations optimization, and Europe implementation. The firm applies its proprietary evidence generation methodology to help clients optimize development with regulators, market access with payers, and adoption by healthcare professionals. Services are delivered across multiple healthcare sectors including pharmaceuticals, medical devices, biotechnology, e-health, and medically positioned dietary supplements.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Development Advisory Expert guidance on clinical trial planning, execution, and development strategy to reduce research timelines and generate robust data supporting market access, for pharmaceutical, biotech, and medical device companies.
• Regulatory Europe Services Strategic consulting for navigating European regulatory requirements and obtaining market authorisation across EU member states, for healthcare companies targeting the European market.
• Market Access Consulting Strategic advisory on pricing, reimbursement strategies, and market access conditions to optimise commercial success in France and Europe, for pharmaceutical, biotech, and medical device companies.
• Real World Evidence Solutions Analysis and utilisation of real-life health data and digital tools for evidence generation and decision support throughout the drug lifecycle, for pharmaceutical, biotech, and medical device companies.
• Medical Affairs Support Expertise in medical strategy, scientific communication, and relationship management with healthcare professionals and institutions, for pharmaceutical and biotech companies.
• Public Affairs & Government Relations Strategic counsel on healthcare policy, stakeholder engagement, and institutional relations at national and European levels, for pharmaceutical, biotech, and healthcare organisations.
• Product Life Cycle Management Comprehensive lifecycle strategy from early access through commercialisation and post-marketing optimisation, for pharmaceutical and biotech companies.
• Operational Excellence Consulting Organisational efficiency and performance optimisation for healthcare companies operating in European markets.
• Valuation of Opportunities Economic evaluation and opportunity assessment for healthcare products and business development decisions, for pharmaceutical and biotech companies.
• Europe Implementation Services Market entry and operational setup support for companies establishing presence in European healthcare markets.
• Organisations Optimisation Organisational design and restructuring advisory to enhance effectiveness of healthcare companies and cross-functional collaboration.
• Marketing/Promotion Strategy Commercial strategy and promotional tactics development for pharmaceutical and healthcare products.

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• Blue Matter Consulting: Specialist life sciences strategy consulting firm focused on biopharma commercial strategy, market access, and launch excellence in Europe and the US. Directly comparable boutique healthcare consulting peer serving similar pharma client mandates.
• ZS Associates: Specialist management consulting firm focused on healthcare, with deep practices in market access, real-world evidence, and commercial strategy for pharma and medtech. Directly comparable to Euresis in service mix, though significantly larger and with proprietary data/analytics assets.
• Simon-Kucher & Partners: Global consulting firm specialised in pricing, market access, and commercial strategy for healthcare and life sciences clients. Closely comparable on market access and pricing advisory offerings that overlap with Euresis's market access and valuation modules.
• Charles River Associates (Healthcare): Global consulting firm with a life sciences practice advising pharma and biotech on commercial strategy, market access, and pricing. Directly comparable on healthcare strategy advisory services though with broader economics and litigation capabilities.
• Triangle Insights Group: Boutique strategy consulting firm serving biopharmaceutical clients on commercial strategy, market access, and therapeutic area planning. Highly comparable boutique model, healthcare-only focus, and overlap with Euresis on market access and lifecycle planning services.
• Putnam Associates: Boutique life sciences strategy consulting firm advising pharma and biotech on market access, commercial strategy, and portfolio decisions. Closely comparable boutique model and service scope to Euresis, focused on healthcare clients in Europe and globally.

Broad incumbents

• Bain & Company (Healthcare): Top-tier global consultancy with a dedicated healthcare practice advising pharma, biotech, and medtech on strategy and market access. Competes for the same European pharma client budget and mandates Euresis targets, but with global delivery capacity Euresis cannot match.
• Huron Consulting Group (Healthcare): US-listed professional services firm with a healthcare practice advising providers, payers, and life sciences companies on strategy, operations, and digital transformation. Adjacent healthcare consulting peer with overlapping pharma/biotech commercial advisory services.
• McKinsey & Company (Healthcare Practice): Global management consulting leader with a deep healthcare and pharma practice covering market access, R&D, and operations. Comparable because Euresis competes for the same senior pharma/biotech advisory mandates, though McKinsey operates at vastly larger scale and global footprint.
• IQVIA: Global healthcare data, analytics, and consulting powerhouse advising pharma across clinical development, real-world evidence, and market access. Overlaps with Euresis on consulting services but pairs them with proprietary datasets and technology platforms Euresis does not offer.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/sharer.php?u=https://www.euresispartners.com/en/euresis-partners-creation
• LinkedInlinkedin.com/company/euresis-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EURESIS PARTNERS